Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain

NANot yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

October 1, 2024

Study Completion Date

December 1, 2024

Conditions
Pain Cancer
Interventions
DEVICE

Ultrasound-guided percutaneous neuromodulation (NMP)

Epte Bipolar System is a medical device for health professionals that combines several techniques that extend the therapeutic variety of electrostimulation, for the treatment of different pathologies of the musculoskeletal system and peripheral and central nervous system. It is a nationally manufactured device that meets all quality standards, being the perfect tool for the application of techniques such as transcranial direct current stimulation. It is a versatile, compact, portable and easy to use equipment that has the ability to adapt the parameters to achieve any protocol established by scientific evidence to treat the various pathologies. The Epte® Bipolar System device has an CE Health Certificate

DRUG

pharmacological treatment by Opioids

Opioid analgesics are the main option for pain treatment in cancer patients, but their side effects and inadequate treatment lead to cheaper, quicker options with lower risk of addiction and/or side effects.

Trial Locations (1)

38002

Centro RED Tenerife, Santa Cruz de Tenerife

All Listed Sponsors
lead

Universidad Europea de Canarias

OTHER

NCT06240390 - Effectiveness of Percutaneous Neuromodulation vs Pharmacological Treatment in Cancer Patients With Anterior Knee Pain | Biotech Hunter | Biotech Hunter